You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 213 No. 4, July 27, 1970 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

T3 Thyrotoxicosis

Thyrotoxicosis Due to Elevated Serum Triiodothyronine Levels

Kenneth Sterling, MD; Samuel Refetoff, MD; Herbert A. Selenkow, MD

JAMA. 1970;213(4):571-575.


Abstract

Thyrotoxicosis may be caused by elevated serum triiodothyronine (T3) in the presence of normal thyroxine (T4) concentration. Of a series of 26 selected cases, 12 have been observed in patients with toxic nodular goiter, most typically with a solitary hyperfunctioning nodule, but also with multinodular goiters. The disorder has also been observed in seven patients with classical toxic diffuse goiter (Graves' disease) including two patients with typical infiltrative ophthalmopathy. The diagnosis of T3 thyrotoxicosis should be suspected when there are clinics and laboratory evidences of hypermetabolism in the presence of normal serum T4 and the absence of thyroxine-binding globulin (TBG) abnormalities. Until T3 measurement becomes more readily available, it is advisable to employ screening with the T3 suppression test, regardless of the initial 24-hour thyroidal radioactive iodine uptake value.



Author Affiliations

From the Protein Research Laboratory, Bronx Veterans Administration Hospital and the Department of Pathology, Columbia University College of Physicians and Surgeons and the Department of Medicine, Harlem Hospital Center, New York (Dr. Sterling) and the Department of Medicine, Peter Bent Brigham Hospital and Harvard Medical School, Boston (Drs. Refetoff and Selenkow). Dr. Refetoff is now with the University of Chicago, Pritzker School of Medicine, Chicago.


Footnotes

Reprint requests to 130 W Kingsbridge Rd, Bronx, NY 10468 (Dr. Sterling).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A Case of Thyroxine Thyrotoxicosis
Blank and Tucci
Arch Intern Med 1987;147:863-864.
ABSTRACT  

Levels of Serum Thyroid-Stimulating Hormone in Hyperthyroidism
Smith et al.
Arch Intern Med 1979;139:757-760.
ABSTRACT  

Thyroid Physiology in Health and Disease
BROWN et al.
ANN INTERN MED 1974;81:68-81.
ABSTRACT  

Tachycardia-Aggravated Heart Disease
ENGEL et al.
ANN INTERN MED 1974;80:384-388.
ABSTRACT  

Triiodothyronine: Physiological and Clinical Significance
Gharib
JAMA 1974;227:302-304.
ABSTRACT  

Recurrent Hyperthyroidism Presenting as Triiodothyronine Toxicosis
SHENKMAN et al.
ANN INTERN MED 1972;77:410-413.
ABSTRACT  

Triiodothyronine Thyrotoxicosis
S.V.
JAMA 1971;218:438-439.
ABSTRACT  

"Triiodothyronine (T3) Toxicosis" Its Role in Graves' Disease
Ivy et al.
Arch Intern Med 1971;128:529-534.
ABSTRACT  

Eyelids, Lacrimal Apparatus, and Conjunctiva
Sexton
Arch Ophthalmol 1971;85:379-396.
 





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1970 American Medical Association. All Rights Reserved.